T. A. Jackson et al. / Bioorg. Med. Chem. 17 (2009) 1514–1526
1523
4.1.5. Methyl 2,4,6-tri-O-benzoyl-3-O-[2-deoxy-2-(2,2,2-
trichlorethoxycarbonylamino)-b-D-glucopyranosyl]-b-D-
galactopyranoside (8)
layers were washed with water (30 mL), combined, dried and con-
centrated. Chromatography (6:4 hexanes–EtOAc) of the residue
gave the disaccharide acceptor 11 (148 mg, 86%) pure as a white
AcCl (400
lL) was added to a solution of disaccharide 7
amorphous powder. [a]
D = +16 (c 1.2, CHCl3). 1H NMR (300 MHz,
(206 mg, 0.21 mmol) in MeOH (5 mL) and the reaction mixture
was stirred overnight under N2 at room temperature. Solid NaHCO3
was added to the reaction mixture, solids were filtered off and
washed with MeOH (10 mL). The filtrate and washings were com-
bined, concentrated and chromatography of the crude residue
(49:1 CHCl3–MeOH) gave triol 8 (138 mg 77%) pure as a colorless
CDCl3): d 8.15–7.28 (m, 20H, Ar), 5.84 (d, 1H, J = 3.0 Hz, H-4),
5.54 (dd, 1H, J = 7.9, 9.9 Hz, H-2), 4.98 (t, 1H, J = 9.8 Hz, H-30),
4.81 (d, 1H, J = 8.1 Hz, H-10), 4.74 (d, 1H, J = 8.1 Hz, NH), 4.59–4.
45 (m, 5H, H-1, H-6a, H-6b, CH2Ph), 4.21 (dd, 1H, J = 10.0, 3.1 Hz,
H-3), 4.13 (t, 1H, J = 7.1 Hz, H-5), 4.03 (dd, 1H, J = 11.9 Hz,
OCHHCCl3), 3.93 (dd, 1H, J = 12.1 Hz, OCHHCCl3), 3.74 (dd, 1H,
J = 4.06, 10.4 Hz, H-60a), 3.79 (dd, 1H, J = 10.4 Hz, H-60b), 3.66 (t,
1H, J = J = 9.1 Hz, H-40), 3.50 (br s, 4H, H-50,CH3O), 3.29 (q, 1H,
J = 9.0 Hz, H-20), 3.07 (br s, 1H, OH), 1.93 (s, 3H, CH3CO). 13C NMR
(75 MHz, CDCl3): d 172.3, 166.6, 165.7 (CO), 137.5-128.3 (Ar),
108.7 (C-1), 101.7 (C-10), 95.6 (CCl3), 77.9 (C-3), 74.6 (C-30, C-50),
74.2 (OCH2CCl3, CH2Ph), 72.0 (C-5), 71.8 (C-2), 70.7 (C-40), 70.3
(C-4), 69.6 (C-60), 57.4 (CH3O, C-20), 21.0 (CH3CO). HRMS calcd for
C46H46Cl3NO16 [M+Na]+ 996.1780, found 996.1779.
glass. [a]
D = +10 (c 0.7, MeOH). 1H NMR (400 MHz, CDCl3): d
8.18–7.38 (m, 15H, Ar), 5.99 (d, 1H, J = 3.2 Hz, H-4), 5.56 (dd, 1H,
J = 8.1, 9.6 Hz, H-2), 5.31 (d, 1H, J = 6.7 Hz, NH), 4.81 (br d, 1H,
J = 6.4 Hz, H-10), 4.62–4. 50 (m, 2H, H-1, H-6a), 4.38 (dd, 1H,
J = 5.8, 11.5 Hz, H-6b), 4.22–4. 01 (m, 3H, H-3, H-5, OCHHCCl3),
3.82–3.52 (m, 6H, H-30, H-60a, H-60b, OCHHCCl3, 2 ꢂ OH), 3.51 (s,
1H, CH3O), 3.27 (br s, 1H, H-50), 3.28 (br s, 1H, H-40), 2.85 (br s,
1H, H-20), 2.00 (br s, 1H, OH). 13C NMR (100 MHz, CDCl3): d
167.0, 166.6, 165.7, 154.6 (CO), 134.2, 133.8, 130.7, 130.4, 130.1,
129.9, 129.4, 129.0, 128.9 (Ar), 102.6 (C-1, C-10), 76.2, 71.7, 70.9
(C-2, C-3, C-4, C-5, C-30, C-40, C-50, OCH2CCl3), 62.7 (C-6), 61.6 (C-
60), 58.8 (C-20), 57.4 (CH3O). HRMS calcd for C37H38Cl3NO15
[M+Na]+ 864.1205, found 864.1160.
4.1.8. Methyl 3-O-[3,4-di-O-acetyl-6-O-benzyl-2-deoxy-2-(2,2,2-
trichlorethoxycarbonylamino)-b-
D-glucopyranosyl]-2,4,6-tri-O-
benzoyl-b- -galactopyranoside (12)
D
A solution of the alcohol 11 (16.0 mg, 0.02 mmol) in Ac2O
(0.2 mL) and pyridine (0.4 mL) was stirred under N2 at room tem-
perature for 2 h. Solvents were co-evaporated with toluene, and
the crude product was purified by chromatography (6:4 hex-
anes–EtOAc) to yield the pure diacetate 12 (11.3 mg, 68%).
4.1.6. Methyl 3-O-[3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-
(2,2,2-trichlorethoxycarbonylamino)-b-
2,4,6-tri-O-benzoyl-b- -galactopyranoside (10)
Benzaldehyde dimethyl acetal (480 L, 3.20 mmol) and TsOH
D-glucopyranosyl]-
D
l
[a]
D = +36 (c 0.9, CHCl3). 1H NMR (400 MHz, CDCl3): d 8.18–7.21
(92 mg, 0.53 mmol) were added to a solution of triol 8 (1.28 g,
1.52 mmol) in DMF (29 mL) and the solution was stirred at 80 °C
for 1 h. Et3N (80 lL) was added to the reaction mixture, solvents
(m, 20H, Ar), 5.88 (d, 1H, J = 3.2 Hz, H-4), 5.60 (dd, 1H, J = 8.1,
9.7 Hz, H-2), 5.30 (t, 1H, J = 9.9 Hz, H-3’), 4.95–4.84 (m, 2H, H-10,
H-40), 4.77 (d, 1H, J = 7.9 Hz, NH), 4.55–4.42 (m, 5H, H-1, H-6a, H-
6b, CH2Ph), 4.20–4.10 (m, 2H, H-3, OCHHCCl3), 4.05 (t, 1H,
J = 6.3 Hz, H-5), 3.78 (d, 1H, J = 12.1 Hz, OCHHCCl3), 3.70–3.61 (m,
1H, H-50), 3.60–3.50 (m, 2H, H-60a, H-60b), 3.50 (s, 1H, CH3O),
3.21 (q, 1H, J = 8.9 Hz, H-20), 1.87 (2s, 2 ꢂ 3H, 2 ꢂ CH3CO). 13C
NMR (75 MHz, CDCl3): d 171.8, 166.1, 154.3, 153.2 (CO), 144.1,
138.0, 133.4, 133.3, 133.1, 130.2, 130.0, 130.0, 128.6, 128.4, 127.7
(Ar), 117.1 (CCl3) 102.2 (C-1, C-10), 73.6 (OCH2CCl3, CH2Ph), 73.4,
72.3, 69.9 (C-2, C-4, C-5, C-30, C-40), 69.7 (C-60), 62.9 (C-6), 57.1
(CH3O), 56.5 (C-20), 20.6, 20.4 (CH3CO). HRMS calcd for
C48H48Cl3NO17 [M+NH4]+ 1033.2332, found 1033.2343.
were evaporated and the crude residue was dissolved in pyridine
(10 mL) and Ac2O (5 mL). The solution was stirred under N2 at room
temperature for 1.5 h diluted with water (ꢁ20 mL) and extracted
with CH2Cl2 (3 ꢂ ꢁ20 mL). The combined organic phases were
washed successively with 1 M HCl, satd aq NaHCO3 and water and
theaqueouslayerswerere-extractedwithCH2Cl2. Theorganiclayers
were combined, dried, concentrated, and chromatography (3:1 hex-
anes–EtOAc) of the residue gave disaccharide 10 (1.38 g, 94%) pure
as an amorphous powder. [a]
D = +13 (c 3.1, CHCl3). 1H NMR
(400 MHz, CDCl3): d 8.18–7.31 (m, 20H, Ar), 5.81 (d, 1H, J = 2.9 Hz,
H-4), 5.62 (dd, 1H, J = 8.1, 9.7 Hz, H-2), 5.42 (s, 1 H, CHPh), 5.25 (t,
1H, J = 9.8 Hz, H-30), 4.82 (d, 1H, J = 8.2 Hz, H-10), 4.73 (d, 1H,
J = 8.6 Hz, NH), 4.57 (d, 1H, J = 7.9 Hz, H-1), 4.54–4. 46 (m, 2H, H-
6a, H-6b), 4.31 (dd, 1H, J = 4.8, 10.7 Hz, H-60a), 4.20–4.10 (m, 3H,
H-3, H-5, OCHHCCl3), 4.03 (d, 1H, J = 12.2 Hz, OCHHCCl3), 3.67 (t,
1H, J = 10.2 Hz, H-60b), 3.59–3.32 (m, 6H, H-20, H-40, H-50, CH3O),
1.91 (s, 3H, CH3CO). 13C NMR (100 MHz, CDCl3): d 166.6, 165.4
(CO), 137.2, 133.9, 133.7, 130.3, 130.1, 129.5, 129.1, 128.9, 128.6,
126.5 (Ar), 102.6, 101.7 (C-1, C-10, CHPh), 95.8 (CCl3), 78.8 (C-3, C-
40), 74.2 (OCH2CCl3), 72.1, 71.7, 70.4 (C-2, C-4, C-5, C-30), 68.7 (C-
60), 66.7 (C-50), 63.3 (C-6), 57.3 (C-20, CH3O), 21.0 (CH3CO). HRMS
calcd for C46H44Cl3NO16 [M+H]+ 972.1804, found 972.1762.
4.1.9. Methyl 3-O-[3-O-acetyl-6-O-benzyl-4-O-(2,3,4-tri-O-
benzyl-
trichlorethoxycarbonylamino)-b-
benzoyl-b- -galactopyranoside (15)
a
-
L
-fucopyranosyl)-2-deoxy-2-(2,2,2-
D-glucopyranosyl]-2,4,6-tri-O-
D
Method A. A solution of acceptor 11 (93.1 mg, 0.10 mmol), thio-
glycoside donor 13 (162 mg, 0.34 mmol) in Et2O (5 mL) containing
activated powdered 4 Å molecular sieves (173 mg) was stirred un-
der N2 at room temperature for 1 h. MeOTf (53
added and the mixture was stirred at room temperature for an
additional 1.5 h. Et3N (63 L) was added to the mixture; the solids
lL, 0.47 mmol) was
l
were filtered off and washed with Et2O (ꢁ10 mL). The filtrate and
washings were combined, concentrated and centrifugal purifica-
tion (17:3 to 7:3 hexanes–EtOAc) of the crude residue gave trisac-
charide 15 (114 mg, 85%) pure as an amorphous powder.
4.1.7. Methyl 3-O-[3-O-acetyl-6-O-benzyl-2-deoxy-2-(2,2,2-
trichlorethoxycarbonylamino)-b-
D-glucopyranosyl]-2,4,6-tri-O-
benzoyl-b- -galactopyranoside (11)
D
Method B. Coupling of the acceptor 11 (29.6 mg, 0.03 mmol),
NaCNBH3 (165 mg, 2.63 mmol) and activated 3 Å molecular
sieves (0.66 g) were added to a solution of benzylidene acetal 10
(172 mg, 0.18 mmol) stirred under N2 at room temperature in an-
hyd THF (3.8 mL). A solution of HCl in Et2O (2.0 M, 1.7 mL,
3.4 mmol) was then added dropwise until the evolution of gas
had ceased and the mixture remained acidic (litmus paper). The
mixture was stirred at room temperature for 45 min, decanted into
a separatory funnel and satd aq NaHCO3 (20 mL) was added. The
mixture was extracted with CH2Cl2 (2 ꢂ ꢁ20 mL) and the organic
and thioglycoside 14 (51.5 mg, 0.11 mmol) under MeOTf (20 lL,
0.18 mmol) activation was carried out in Et2O (1.5 mL) as de-
scribed above for the coupling of acceptor 11 with donor 13. Work
up, as described above, followed by column chromatography (7:3
hexanes–EtOAc) of the crude residue gave trisaccharide 15
(32.5 mg, 77%) pure.
Analytical data for 15.
(300 MHz, CDCl3):
[
a
]
D = ꢀ3 (c 1.8, CHCl3). 1H NMR
d
8.18–7.15 (m, 35H, Ar), 5.84 (d, 1H,
J = 2.6 Hz, H-4), 5.58 (br t, 1H, J = 8.8 Hz, H-2), 5.02 (br t, 1H,